Mingxin Wen

854 total citations
17 papers, 615 citations indexed

About

Mingxin Wen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mingxin Wen has authored 17 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Mingxin Wen's work include Ubiquitin and proteasome pathways (6 papers), RNA modifications and cancer (4 papers) and Cancer-related gene regulation (3 papers). Mingxin Wen is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), RNA modifications and cancer (4 papers) and Cancer-related gene regulation (3 papers). Mingxin Wen collaborates with scholars based in China, United States and Austria. Mingxin Wen's co-authors include Guangwei Wei, Jian‐Hua Mao, Yunshan Wang, Pengju Zhang, Yong-Won Kwon, Xiuquan He, Qin Wang, Yuli Wang, Yongsheng Wang and Yurong Huang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Mingxin Wen

17 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxin Wen China 10 520 229 167 47 47 17 615
Zejun Fang China 15 381 0.7× 196 0.9× 169 1.0× 77 1.6× 51 1.1× 27 548
Yuli Jia China 13 408 0.8× 279 1.2× 123 0.7× 34 0.7× 53 1.1× 14 567
Shuet Theng Lee Singapore 5 576 1.1× 216 0.9× 173 1.0× 67 1.4× 78 1.7× 5 715
Weimei Tang China 13 357 0.7× 199 0.9× 99 0.6× 73 1.6× 45 1.0× 21 447
Baoxin Qian China 9 345 0.7× 221 1.0× 113 0.7× 38 0.8× 29 0.6× 18 512
Yanmei Cui China 13 450 0.9× 333 1.5× 138 0.8× 77 1.6× 68 1.4× 16 641
Yun Seong Jeong United States 9 397 0.8× 143 0.6× 147 0.9× 40 0.9× 41 0.9× 17 499
Shi-Xun Lu China 12 381 0.7× 286 1.2× 142 0.9× 74 1.6× 27 0.6× 12 572
Aleksandra Balwierz Germany 7 517 1.0× 422 1.8× 127 0.8× 52 1.1× 35 0.7× 10 674
Nicole P. Ho Hong Kong 6 265 0.5× 213 0.9× 137 0.8× 46 1.0× 65 1.4× 9 453

Countries citing papers authored by Mingxin Wen

Since Specialization
Citations

This map shows the geographic impact of Mingxin Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxin Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxin Wen more than expected).

Fields of papers citing papers by Mingxin Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxin Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxin Wen. The network helps show where Mingxin Wen may publish in the future.

Co-authorship network of co-authors of Mingxin Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxin Wen. A scholar is included among the top collaborators of Mingxin Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxin Wen. Mingxin Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wen, Mingxin, et al.. (2024). Regulation of HNRNP family by post-translational modifications in cancer. Cell Death Discovery. 10(1). 427–427. 6 indexed citations
2.
Tian, Jie, Mingxin Wen, Peng Gao, Maoxiao Feng, & Guangwei Wei. (2024). RUVBL1 ubiquitination by DTL promotes RUVBL1/2-β-catenin-mediated transcriptional regulation of NHEJ pathway and enhances radiation resistance in breast cancer. Cell Death and Disease. 15(4). 259–259. 7 indexed citations
3.
Wen, Mingxin, et al.. (2024). UBE2T mediates the stemness properties of breast cancer cells through the mTOR signaling pathway. Biocell. 48(6). 959–970. 2 indexed citations
4.
Dong, Guoying, Qin Wang, Mingxin Wen, et al.. (2023). DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer. Oncogene. 42(40). 3000–3014. 9 indexed citations
5.
Chen, Hong‐Yuan, Meng Kong, Ying Chen, et al.. (2021). Prognostic significance of miR-203 and ZEB1 expression in early-stage hepatocellular carcinoma. Journal of Cancer. 12(16). 4810–4818. 5 indexed citations
6.
Wen, Mingxin, et al.. (2021). CT45A1 promotes the metastasis of osteosarcoma cells in vitro and in vivo through β-catenin. Cell Death and Disease. 12(7). 650–650. 13 indexed citations
7.
Li, Jing, Fengqin Wang, Junmin Wei, et al.. (2021). Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysis. Cell Reports. 37(12). 110137–110137. 20 indexed citations
8.
Du, Lutao, Yidan Ren, Xiaoyan Liu, et al.. (2019). SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination. Journal of Experimental & Clinical Cancer Research. 38(1). 86 indexed citations
9.
Wen, Mingxin, et al.. (2018). TCEA1 regulates the proliferative potential of mouse myeloid cells. Experimental Cell Research. 370(2). 551–560. 7 indexed citations
10.
Liu, Xiaoyan, Lei Bi, Qin Wang, et al.. (2018). miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer. Oncogene. 37(25). 3426–3439. 52 indexed citations
11.
Zhang, Xiaoni, Ligang Xia, Mingyan Xu, et al.. (2018). ctDNA sequencing for early detection of colorectal cancers: Comparative analysis of colon cancer and rectal cancer data.. Journal of Clinical Oncology. 36(15_suppl). e15653–e15653. 3 indexed citations
12.
Zhan, Panpan, Yuli Wang, Chunyan Liu, et al.. (2015). FBXW7 negatively regulates ENO1 expression and function in colorectal cancer. Laboratory Investigation. 95(9). 995–1004. 60 indexed citations
13.
Wen, Mingxin, Yong-Won Kwon, Yongsheng Wang, Jian‐Hua Mao, & Guangwei Wei. (2015). Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer. Oncotarget. 6(28). 25226–25239. 69 indexed citations
14.
Wang, Yunshan, Pengju Zhang, Ziming Liu, et al.. (2014). CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR. Molecular Cancer. 13(1). 252–252. 43 indexed citations
15.
Wang, Yunshan, Mingxin Wen, Yong-Won Kwon, et al.. (2013). CUL4A Induces Epithelial–Mesenchymal Transition and Promotes Cancer Metastasis by Regulating ZEB1 Expression. Cancer Research. 74(2). 520–531. 157 indexed citations
16.
Lü, Jing, Mingxin Wen, Yurong Huang, et al.. (2013). C2ORF40suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes. Epigenetics. 8(6). 571–583. 40 indexed citations
17.
Wang, Yunshan, Qin Wang, Mingxin Wen, et al.. (2013). Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells. Molecules. 19(1). 159–176. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026